CONMED Corporation (CNMD) News
Filter CNMD News Items
CNMD News Results
|Loading, please wait...|
CNMD News Highlights
- For CNMD, its 30 day story count is now at 3.
- Over the past 24 days, the trend for CNMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- MSCI and HSIC are the most mentioned tickers in articles about CNMD.
Latest CNMD News From Around the Web
Below are the latest news stories about CONMED Corp that investors may wish to consider to help them evaluate CNMD as an investment opportunity.
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HSIC vs. CNMD: Which Stock Is the Better Value Option?
Naperville, IL, based Investment company Calamos Wealth Management Llc (Current Portfolio) buys SPDR Bloomberg Convertible Securities ETF, iShares Core S&P Small-Cap ETF, iShares MSCI ACWI Ex US Index Fund, Broadcom Inc, Boeing Co, sells PayPal Holdings Inc, Vonage Holdings Corp, ServiceNow Inc, BTC iShares MSCI EAFE Min Vol Factor ETF, Southwest Airlines Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Calamos Wealth Management Llc.
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
CONMED Corporation (NYSE: CNMD ) reported Q4 FY21 adjusted EPS of $1.07 , compared to $0.84 a year ago, and better than the consensus of $1.06. Sales for the quarter rose 8.4% Y/Y to $273.97 million, missing the consensus of $278.76 … Full story available on Benzinga.com
CONMED's (CNMD) fourth-quarter earnings reflect strong segmental performance.
No summary available.
Conmed (CNMD) delivered earnings and revenue surprises of 1.90% and 1.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
LARGO, Fla., January 26, 2022--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2021.
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.